Phase I/II Trial of MUC1*-CAR-1XX T Cells

被引：0

作者：

Bamdad, Cynthia ^{[1
]}

Mortimer, Joanne ^{[2
]}

Yuan, Yuan ^{[2
]}

Specht, Jennifer ^{[3
]}

Stewart, Andrew ^{[1
]}

Smagghe, Benoit ^{[1
]}

Lin, Stephen ^{[2
]}

Carter, Mark ^{[1
]}

Synold, Tim ^{[2
]}

Parekh, Vishwas ^{[2
]}

Walkley, Danica ^{[1
]}

Budde, Lihua E. ^{[2
]}

Liu-Michael, Qing ^{[2
]}

Yi, Kevin ^{[1
]}

Nash, Jac-Leen ^{[1
]}

Nash, Michael ^{[1
]}

Marquez, Jacy ^{[1
]}

Kim, Teresa ^{[2
]}

Hamilton, Stan ^{[2
]}

Forman, Stephen J. ^{[2
]}

机构：

[1] Minerva Biotechnol, Waltham, MA USA

[2] City Hope Natl Med Ctr, Duarte, CA USA

[3] Fred Hutchinson Canc Ctr, Seattle, WA USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

804

引用

页码：397 / 397

页数：1

共 50 条

[1] MUC1*targeting CAR T
Bamdad, Cynthia Carol
Stewart, Andrew K.
Smagghe, Benoit J.
Deary, Luke T.
Kohler, Victoria L.
Dietz, Jared L.
CANCER RESEARCH, 2017, 77
[2] Phase I/II first-in-human CAR T-targeting MUC1 transmembrane cleavage product (MUC1*) in patients with metastatic breast cancer
Bamdad, Cynthia Carol
Yuan, Yuan
Specht, Jennifer M.
Stewart, Andrew K.
Smagghe, Benoit J.
Lin, Stephen Chi-Min
Carter, Mark G.
Synold, Timothy W.
Frankel, Paul Henry
Parekh, Vishwas
Walkley, Danica M.
Budde, L. Elizabeth
Liu-Michael, Qing
Nash, Jac-Leen
Nash, Michael J.
Reale, Laura M.
Yi, Kevin Y.
Kim, Teresa
Hamilton, Stanley R.
Forman, Stephen J.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[3] CAR T cells that target full-length MUC1 enrich for MUC1*and induce metastasis
Bamdad, Cynthia C.
Stewart, Andrew K.
Deary, Luke T.
Smagghe, Benoit J.
Huang, Pengyu
Glennie, Nelson D.
Swanson, Tyler E.
CANCER RESEARCH, 2018, 78 (13)
[4] Phase I clinical trial with PD-1/MUC1 CAR-pNK92 immunotherapy
Li, Qiao
Wang, Yi
Lin, Ming
Xia, Leiming
Bao, Yangyi
Sun, Xiang
Yang, Lin
CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
[5] Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial
Gabriele Pecher
Arnt Häring
Lothar Kaiser
Eckhard Thiel
Cancer Immunology, Immunotherapy, 2002, 51 : 669 - 673
[6] Mucin gene (MUC1) transfected dendritic cells as vaccine:: results of a phase I/II clinical trial
Pecher, G
Häring, A
Kaiser, L
Thiel, E
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (11-12) : 669 - 673
[7] Phase I first-in-human MUC1*targeted autologous CAR T cells for the treatment of metastatic breast cancers
Bamdad, Cynthia Carol
Mortimer, Joanne E.
Yuan, Yuan
Specht, Jennifer M.
Stewart, Andrew K.
Smagghe, Benoit J.
Lin, Stephen C.
Carter, Mark G.
Synold, Tim W.
Fleming, Mark D.
Hamilton, Stanley R.
Parekh, Vishwas
Walkley, Danica M.
Liu-Michael, Qing
Yi, Kevin R.
Nash, Jac-Leen S.
Nash, Michael J.
Forman, Stephen J.
CANCER RESEARCH, 2024, 84 (07)
[8] Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells
Maher, John
Wilkie, Scott
Davies, David M.
Arif, Sefina
Picco, Gianfranco
Julien, Sylvain
Foster, Julie
Burchell, Joy
Taylor-Papadimitriou, Joyce
IMMUNITY, 2016, 45 (05) : 945 - 946
[9] Phase I study of adoptive immunotherapy for advanced MUC1*positive breast cancer with autologous T cells engineered to express a chimeric antigen receptor, huMNC2-CAR44 specific for a cleaved form of MUC1 (MUC1*).
Specht, Jennifer M.
Maloney, David G.
Yeung, Cecilia
Wu, Vicky
Bamdad, Cynthia
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[10] Phase I study of adoptive immunotherapy for advanced MUC1*positive breast cancer with autologous T cells engineered to express a chimeric antigen receptor, huMNC2-CAR44 specific for a cleaved form of MUC1 (MUC1*)
Specht, Jennifer Marie
Maloney, David
Yeung, Cecilia
Wu, Qian
Bamdad, Cynthia
CANCER RESEARCH, 2021, 81 (04)

← 1 2 3 4 5 →